![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 789 |
FusionGeneSummary for ADAR_SUMO3 |
![]() |
Fusion gene information | Fusion gene name: ADAR_SUMO3 | Fusion gene ID: 789 | Hgene | Tgene | Gene symbol | ADAR | SUMO3 | Gene ID | 103 | 6613 |
Gene name | adenosine deaminase, RNA specific | small ubiquitin-like modifier 2 | |
Synonyms | ADAR1|AGS6|DRADA|DSH|DSRAD|G1P1|IFI-4|IFI4|K88DSRBP|P136 | HSMT3|SMT3B|SMT3H2|SUMO3|Smt3A | |
Cytomap | 1q21.3 | 17q25.1 | |
Type of gene | protein-coding | protein-coding | |
Description | double-stranded RNA-specific adenosine deaminase136 kDa double-stranded RNA-binding proteinadenosine deaminase acting on RNA 1-AdsRNA adenosine deaminasedsRNA adeonosine deaminaseinterferon-induced protein 4interferon-inducible protein 4 | small ubiquitin-related modifier 2SMT3 homolog 2SMT3 suppressor of mif two 3 homolog 2sentrin 2ubiquitin-like protein SMT3Aubiquitin-like protein SMT3B | |
Modification date | 20180524 | 20180523 | |
UniProtAcc | P55265 | P55854 | |
Ensembl transtripts involved in fusion gene | ENST00000292205, ENST00000368474, ENST00000368471, ENST00000471068, | ENST00000397898, ENST00000332859, ENST00000479153, ENST00000411651, ENST00000397893, | |
Fusion gene scores | * DoF score | 7 X 6 X 6=252 | 5 X 5 X 2=50 |
# samples | 7 | 5 | |
** MAII score | log2(7/252*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/50*10)=0 | |
Context | PubMed: ADAR [Title/Abstract] AND SUMO3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ADAR | GO:0006382 | adenosine to inosine editing | 15858013|19651874|21289159 |
Hgene | ADAR | GO:0016553 | base conversion or substitution editing | 9020165 |
Hgene | ADAR | GO:0031054 | pre-miRNA processing | 23622242 |
Hgene | ADAR | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA | 23622242 |
Hgene | ADAR | GO:0035455 | response to interferon-alpha | 16475990 |
Hgene | ADAR | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation | 19651874 |
Hgene | ADAR | GO:0045070 | positive regulation of viral genome replication | 19651874 |
Tgene | SUMO3 | GO:0016925 | protein sumoylation | 17081986|17696781|21965678|24105744 |
Tgene | SUMO3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 18408734 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SARC | TCGA-3B-A9HO-01A | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000292205 | ENST00000397898 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
In-frame | ENST00000292205 | ENST00000332859 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5CDS-5UTR | ENST00000292205 | ENST00000479153 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5CDS-5UTR | ENST00000292205 | ENST00000411651 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5CDS-5UTR | ENST00000292205 | ENST00000397893 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-3CDS | ENST00000368474 | ENST00000397898 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-3CDS | ENST00000368474 | ENST00000332859 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-5UTR | ENST00000368474 | ENST00000479153 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-5UTR | ENST00000368474 | ENST00000411651 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-5UTR | ENST00000368474 | ENST00000397893 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5UTR-3CDS | ENST00000368471 | ENST00000397898 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5UTR-3CDS | ENST00000368471 | ENST00000332859 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5UTR-5UTR | ENST00000368471 | ENST00000479153 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5UTR-5UTR | ENST00000368471 | ENST00000411651 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
5UTR-5UTR | ENST00000368471 | ENST00000397893 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-3CDS | ENST00000471068 | ENST00000397898 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-3CDS | ENST00000471068 | ENST00000332859 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-5UTR | ENST00000471068 | ENST00000479153 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-5UTR | ENST00000471068 | ENST00000411651 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
intron-5UTR | ENST00000471068 | ENST00000397893 | ADAR | chr1 | 154600331 | - | SUMO3 | chr21 | 46229033 | - |
Top |
FusionProtFeatures for ADAR_SUMO3 |
![]() |
Hgene | Tgene |
ADAR | SUMO3 |
Ubiquitin-like protein which can be covalently attachedto target lysines either as a monomer or as a lysine-linkedpolymer. Does not seem to be involved in protein degradation andmay function as an antagonist of ubiquitin in the degradationprocess. Plays a role in a number of cellular processes such asnuclear transport, DNA replication and repair, mitosis and signaltransduction. Covalent attachment to its substrates requires prioractivation by the E1 complex SAE1-SAE2 and linkage to the E2enzyme UBE2I, and can be promoted by an E3 ligase such as PIAS1-4,RANBP2 or CBX4 (PubMed:11451954, PubMed:18538659,PubMed:21965678). Plays a role in the regulation of sumoylationstatus of SETX (PubMed:24105744). {ECO:0000269|PubMed:11451954,ECO:0000269|PubMed:18538659, ECO:0000269|PubMed:21965678}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 503_571 | -290 | 932 | Domain | DRBM 1 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 614_682 | -290 | 932 | Domain | DRBM 2 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 726_794 | -290 | 932 | Domain | DRBM 3 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 886_1221 | -290 | 932 | Domain | A to I editase |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 503_571 | -67 | 1227 | Domain | DRBM 1 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 614_682 | -67 | 1227 | Domain | DRBM 2 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 726_794 | -67 | 1227 | Domain | DRBM 3 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 886_1221 | -67 | 1227 | Domain | A to I editase |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 716_725 | -290 | 932 | Region | N-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 795_801 | -290 | 932 | Region | C-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 716_725 | -67 | 1227 | Region | N-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 795_801 | -67 | 1227 | Region | C-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 293_360 | -290 | 932 | Repeat | DRADA 2 |
Hgene | >ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 293_360 | -67 | 1227 | Repeat | DRADA 2 |
Tgene | SUMO3 | chr1:154600331 | chr21:46229033 | ENST00000332859 | - | 1 | 4 | 15_92 | 50 | 104 | Domain | Ubiquitin-like |
Top |
FusionGeneSequence for ADAR_SUMO3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_ADAR_ENST00000292205_chr1_154600331_-_SUMO3_ENST00000397898_chr21_46229033_-_134aa MMSPICDQTIDSRLKVEKATWWGRVGGGSRPHWQSPGVRPCPEEVQDPGLSMRQIRFRFDGQPINETDTPAQVRSWLRVVPGRLPICAGW >In-frame_ADAR_ENST00000292205_chr1_154600331_-_SUMO3_ENST00000332859_chr21_46229033_-_102aa MMSPICDQTIDSRLKVEKATWWGRVGGGSRPHWQSPGVRPCPEEVQDPGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_ADAR_ENST00000292205_chr1_154600331_-_SUMO3_ENST00000397898_chr21_46229033_-_402nt ATGATGTCACCAATCTGCGACCAGACCATTGATTCCCGACTGAAGGTAGAGAAGGCTACGTGGTGGGGGAGGGTGGGGGGAGGGTCGCGG CCGCACTGGCAGTCTCCGGGTGTCCGGCCGTGTCCCGAGGAAGTGCAAGACCCGGGCTTGTCAATGAGGCAGATCAGATTCAGGTTCGAC GGGCAGCCAATCAATGAAACTGACACTCCAGCACAGGTACGGAGCTGGCTTCGCGTGGTTCCAGGGCGACTTCCGATTTGTGCGGGCTGG AGATGGAGGACGAGGACACCATCGACGTGTTCCAGCAGCAGACGGGAGGTGTGCCGGAGAGCAGCCTGGCAGGGCACAGTTTCTAGAGGG >In-frame_ADAR_ENST00000292205_chr1_154600331_-_SUMO3_ENST00000332859_chr21_46229033_-_306nt ATGATGTCACCAATCTGCGACCAGACCATTGATTCCCGACTGAAGGTAGAGAAGGCTACGTGGTGGGGGAGGGTGGGGGGAGGGTCGCGG CCGCACTGGCAGTCTCCGGGTGTCCGGCCGTGTCCCGAGGAAGTGCAAGACCCGGGCTTGTCAATGAGGCAGATCAGATTCAGGTTCGAC GGGCAGCCAATCAATGAAACTGACACTCCAGCACAGCTGGAGATGGAGGACGAGGACACCATCGACGTGTTCCAGCAGCAGACGGGAGGT |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_ADAR_ENST00000292205_chr1_154600331_-_SUMO3_ENST00000397898_chr21_46229033_-_1690nt ATGATGTCACCAATCTGCGACCAGACCATTGATTCCCGACTGAAGGTAGAGAAGGCTACGTGGTGGGGGAGGGTGGGGGGAGGGTCGCGG CCGCACTGGCAGTCTCCGGGTGTCCGGCCGTGTCCCGAGGAAGTGCAAGACCCGGGCTTGTCAATGAGGCAGATCAGATTCAGGTTCGAC GGGCAGCCAATCAATGAAACTGACACTCCAGCACAGGTACGGAGCTGGCTTCGCGTGGTTCCAGGGCGACTTCCGATTTGTGCGGGCTGG AGATGGAGGACGAGGACACCATCGACGTGTTCCAGCAGCAGACGGGAGGTGTGCCGGAGAGCAGCCTGGCAGGGCACAGTTTCTAGAGGG CCCGTCCCCAGCCCGGGCCGTCCATCCTCGCATTGCTGTTGAATGGTGAGCACGTGACCATGCCGACCACAAAGGTGTCTGCGGAAACTC GAGGACATTCACCACGATGATTTTCCTCTCTTTGATGTACTTCAAGTGCAACTCAAAACTATATCTGCAGGGATGAATCTGTAACTTAAA TTGGGCCAATCAGAATTGTTATCTTTGTTCAGGTAAAATGAGTTGCAAGATATTGTGGGTACTTTTGTGTGCTCATTTGTGTTTTCCCCC CCTCCTACAACATTTTTTTAACCCCAAAATTATAGCCTGAATGTTCGCTTTTAGTCTGGCCAGGGATCTGACTCCTGAGTTGGTTGCCTC TCCCCTGCTCACTCCAGTCACATAGAGAATTGGTGTTTCCCGCAGTGGGGATGCAGCTGTTGGACAGGTATTGGGGGCAAGGTTGGTAGG GAGGACAGACTGTCACTTGCTGTTACAGGCACAGGTGATTAAAATGCTAAATATTGCAAATTTAAGCTTTGTCAGTATATGGAAAAGTTG AAGGGAAAATACTGGAATGCTTCTTCAAAGGTTAAAAAATAACCGAGTCTTTTGGTAATTTGACCCCACGTGCTCTCTGGCCCTCAAGCA TGTAACCTCGGGGTCTGAGGCCCAGGACCCACCCCCCTGCCACCCCTCCCACCCCACTCCCTGCTCAGTACCTGGCGTTGGTACACAGGC AAGGATTGGCACAACCAAAATTGGCCTTTTTCTCCCTCTTAATATTGAAGAAATTCCCACATTTCTCATTTGGTAATGGTGTTGTGGCCT CAGATTTCTTCTAGTATTTGCTTCTGATGAATGATTATGGTCTATACATAAAAAAGTAAGACTAAGTATTGCTGAATTTGCAGTTATGTT GTCGTGTATAAGAGCTACTTCCAAGTGTGGTTACAAATGAACCCATGGAATGATGACTTCATGTTCTTCTCGTGGGTTTGTGCCGTGCTG CTTTCCAAATAGGTATTGAATTTATGCATTAGTCTGGTGATTTCAGTTCTGTGAAATATTTTGGGATCTATACCAATTAAACATTTTCAT AGTTCTGCCTATTGTCCTTCCCTGAGGCTCCATTGCTGCTTGGTGGCCATTCTCTGCCTTTTTACAGTCACCTGAACAATGACCCATCAT CTCTTGCTTGCTTGAAATCTTGCTGAAATGTTCTCATTTCCTGTTTGCTGTATGGGCTCGGGTGGGATGTTTGTTGGCTCTGTTGTGTTT >In-frame_ADAR_ENST00000292205_chr1_154600331_-_SUMO3_ENST00000332859_chr21_46229033_-_1640nt ATGATGTCACCAATCTGCGACCAGACCATTGATTCCCGACTGAAGGTAGAGAAGGCTACGTGGTGGGGGAGGGTGGGGGGAGGGTCGCGG CCGCACTGGCAGTCTCCGGGTGTCCGGCCGTGTCCCGAGGAAGTGCAAGACCCGGGCTTGTCAATGAGGCAGATCAGATTCAGGTTCGAC GGGCAGCCAATCAATGAAACTGACACTCCAGCACAGCTGGAGATGGAGGACGAGGACACCATCGACGTGTTCCAGCAGCAGACGGGAGGT GTGCCGGAGAGCAGCCTGGCAGGGCACAGTTTCTAGAGGGCCCGTCCCCAGCCCGGGCCGTCCATCCTCGCATTGCTGTTGAATGGTGAG CACGTGACCATGCCGACCACAAAGGTGTCTGCGGAAACTCGAGGACATTCACCACGATGATTTTCCTCTCTTTGATGTACTTCAAGTGCA ACTCAAAACTATATCTGCAGGGATGAATCTGTAACTTAAATTGGGCCAATCAGAATTGTTATCTTTGTTCAGGTAAAATGAGTTGCAAGA TATTGTGGGTACTTTTGTGTGCTCATTTGTGTTTTCCCCCCCTCCTACAACATTTTTTTAACCCCAAAATTATAGCCTGAATGTTCGCTT TTAGTCTGGCCAGGGATCTGACTCCTGAGTTGGTTGCCTCTCCCCTGCTCACTCCAGTCACATAGAGAATTGGTGTTTCCCGCAGTGGGG ATGCAGCTGTTGGACAGGTATTGGGGGCAAGGTTGGTAGGGAGGACAGACTGTCACTTGCTGTTACAGGCACAGGTGATTAAAATGCTAA ATATTGCAAATTTAAGCTTTGTCAGTATATGGAAAAGTTGAAGGGAAAATACTGGAATGCTTCTTCAAAGGTTAAAAAATAACCGAGTCT TTTGGTAATTTGACCCCACGTGCTCTCTGGCCCTCAAGCATGTAACCTCGGGGTCTGAGGCCCAGGACCCACCCCCCTGCCACCCCTCCC ACCCCACTCCCTGCTCAGTACCTGGCGTTGGTACACAGGCAAGGATTGGCACAACCAAAATTGGCCTTTTTCTCCCTCTTAATATTGAAG AAATTCCCACATTTCTCATTTGGTAATGGTGTTGTGGCCTCAGATTTCTTCTAGTATTTGCTTCTGATGAATGATTATGGTCTATACATA AAAAAGTAAGACTAAGTATTGCTGAATTTGCAGTTATGTTGTCGTGTATAAGAGCTACTTCCAAGTGTGGTTACAAATGAACCCATGGAA TGATGACTTCATGTTCTTCTCGTGGGTTTGTGCCGTGCTGCTTTCCAAATAGGTATTGAATTTATGCATTAGTCTGGTGATTTCAGTTCT GTGAAATATTTTGGGATCTATACCAATTAAACATTTTCATAGTTCTGCCTATTGTCCTTCCCTGAGGCTCCATTGCTGCTTGGTGGCCAT TCTCTGCCTTTTTACAGTCACCTGAACAATGACCCATCATCTCTTGCTTGCTTGAAATCTTGCTGAAATGTTCTCATTTCCTGTTTGCTG TATGGGCTCGGGTGGGATGTTTGTTGGCTCTGTTGTGTTTATTCACCAATTTGTACATTATTTGTTGTCCTTTACTACTGTAAACAGTAA |
Top |
FusionGenePPI for ADAR_SUMO3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ADAR | XPO1, HDLBP, HDAC5, ELAVL1, HNRNPA1, CUL3, CAND1, DDX17, HNRNPM, UPF1, SNRPN, SNRPB, DHX9, HDAC9, TGM2, UBE2I, FBXO6, TARDBP, RPA1, RPA2, RPA3, ERG, STAU2, STAU1, CUL7, OBSL1, EZH2, SUZ12, EED, RNF2, BMI1, EGFR, USP38, FBXW11, NTRK1, SMC2, SCARNA22, IFI16, MYC, XRCC3, MATR3, THOC1, TACC3, EXOSC4, THOC2, THOC7, MMGT1, ZFC3H1, RBPJ, FOXA2, FOXA3, FOXB1, FOXG1, FOXH1, FOXI2, CRY2, FOXL1, FOXP3, FOXS1, MEX3C, COX15, PDHA1, FOXA1, G3BP1, UBE2A | SUMO3 | SAE1, UBE2I, VIM, SENP2, TDG, UBA2, CHAF1A, UBE3A, MAPKAPK3, TK1, CDKN1A, SMN1, TTR, ANXA7, PFDN1, PML, USP25, USPL1, PIAS1, PIAS2, TDP2, PIAS3, SP100, UPF2, DRAP1, IRF7, SENP1, SENP5, ENO1, MOV10, NXF1, RNF111, DAXX, UBC, HIPK2, ALDOB, ECHS1, ISYNA1, MAPRE1, PROSC, SEC23B, ARHGDIA, DYNLT1, ENO2, FKBP2, MTAP, PFKM, PGD, RAD23A, RAD23B, SEC23A, STIP1, UFD1L, TAGLN2, TAGLN3, UCHL3, EWSR1, SLX4, RNF168, RNF8 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ADAR | chr1:154600331 | chr21:46229033 | ENST00000368471 | - | 1 | 15 | 133_202 | -290 | 932 | Z-DNA |
Hgene | ADAR | chr1:154600331 | chr21:46229033 | ENST00000368474 | - | 1 | 15 | 133_202 | -67 | 1227 | Z-DNA |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ADAR_SUMO3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ADAR_SUMO3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ADAR | C0406775 | Symmetrical dyschromatosis of extremities | 3 | CTD_human;ORPHANET;UNIPROT |
Hgene | ADAR | C0796126 | AICARDI-GOUTIERES SYNDROME 1 | 1 | CTD_human |
Hgene | ADAR | C3539013 | AICARDI-GOUTIERES SYNDROME 6 | 1 | UNIPROT |